AGX840

Recombinant SARS-CoV-2 Nucleocapsid Protein (whole length)

suitable for ELISA

• Synonym(s): 2019-nCoV, SARS-CoV
• UNSPSC Code: 51201600
• NACRES: NA.26

Properties

• recombinant: expressed in E. coli
• Quality Level: 100
• form: liquid
• storage condition: avoid repeated freeze/thaw cycles
• technique(s): ELISA: suitable
• shipped in: dry ice

Description

General description

This e. coli recombinant SARS-CoV-2 Nucleocapsid Protein (whole length), Cat. No. AGX840 is tested for use in ELISA.

Specificity

SARS CoV2

Target description

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the virus strain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. A SARS-CoV-2 nucleocapsid antigen can be used to support the detection of SARS-CoV-2 (COVID-19, 2019-nCoV).

Physical form

Purified recombinant protein in 0.01M PBS, pH7.4

Reconstitution

Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.

Storage and Stability

Stable for 1 year at -20°C from date of receipt. Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Safety Information

• Storage Class Code: 12 - Non Combustible Liquids
• WGK: WGK 2
• Flash Point(F): Not applicable
• Flash Point(C): Not applicable